Čredna imunost (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Čredna imunost" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

54nih.gov

4^th place

8^th place

34doi.org

2^nd place

5^th place

7books.google.com

3^rd place

11^th place

3oxfordjournals.org

1,389^th place

362^nd place

3harvard.edu

18^th place

31^st place

1ox.ac.uk

613^th place

460^th place

1archive.org

6^th place

9^th place

1jstor.org

26^th place

53^rd place

1aappublications.org

3,763^rd place

1,948^th place

1web.archive.org

1^st place

2^nd place

1semanticscholar.org

11^th place

51^st place

1zenodo.org

621^st place

911^th place

1termania.net

low place

34^th place

aappublications.org

pediatrics.aappublications.org

Quadri-Sheriff, M.; Hendrix, K. S.; Downs, S. M.; Sturm, L. A.; Zimet, G. D.; Finnell, S. M. (september 2012). »The role of herd immunity in parents' decision to vaccinate children: a systematic review«. Pediatrics. 130 (3): 522–530. doi:10.1542/peds.2012-0140. PMID 22926181.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

archive.org

*Hinman, A. R.; Orenstein, W. A.; Papania, M. J. (1. maj 2004). »Evolution of measles elimination strategies in the United States«. The Journal of Infectious Diseases. 189 (Suppl 1): S17–22. doi:10.1086/377694. PMID 15106084.
*Sencer, D. J.; Dull, H. B.; Langmuir, A. D. (Marec 1967). »Epidemiologic basis for eradication of measles in 1967«. Public Health Reports. 82 (3): 253–256. doi:10.2307/4592985. JSTOR 4592985. PMC 1919891. PMID 4960501.

books.google.com

Gordis, L. (2013). Epidemiology. Elsevier Health Sciences. str. 26–27. ISBN 978-1455742516. Pridobljeno 29. marca 2015.
Merrill, R. M. (2013). Introduction to Epidemiology. Jones & Bartlett Publishers. str. 68–71. ISBN 978-1449645175. Pridobljeno 29. marca 2015.
Somerville, M.; Kumaran, K.; Anderson, R. (2012). Public Health and Epidemiology at a Glance. John Wiley & Sons. str. 58–59. ISBN 978-1118308646. Pridobljeno 29. marca 2015.
Cliff, A.; Smallman-Raynor, M. (11. april 2013). Oxford Textbook of Infectious Disease Control: A Geographical Analysis from Medieval Quarantine to Global Eradication. Oxford University Press. str. 125–36. ISBN 978-0199596614. Pridobljeno 29. marca 2015.
Rakel, D.; Rakel, R. E. (2015). Textbook of Family Medicine. Elsevier Health Sciences. str. 99, 187. ISBN 978-0323313087. Pridobljeno 30. aprila 2015.
Tulchinsky, T. H.; Varavikova, E. A. (26. marec 2014). The New Public Health: An Introduction for the 21st Century. Academic Press. str. 163–82. ISBN 978-0124157675. Pridobljeno 30. marca 2015.
Fukuda, E.; Tanimoto, J. (2014). Impact of Stubborn Individuals on a Spread of Infectious Disease under Voluntary Vaccination Policy. Springer. str. 1–10. ISBN 978-3319133591. Pridobljeno 30. marca 2015.

doi.org

Fine, P.; Eames, K.; Heymann, D. L. (1. april 2011). »'Herd immunity': A rough guide«. Clinical Infectious Diseases. 52 (7): 911–916. doi:10.1093/cid/cir007. PMID 21427399.
Kim, T. H.; Jonhstone, J.; Loeb, M. (september 2011). »Vaccine herd effect«. Scandinavian Journal of Infectious Diseases. 43 (9): 683–689. doi:10.3109/00365548.2011.582247. PMC 3171704. PMID 21604922.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
*Hinman, A. R.; Orenstein, W. A.; Papania, M. J. (1. maj 2004). »Evolution of measles elimination strategies in the United States«. The Journal of Infectious Diseases. 189 (Suppl 1): S17–22. doi:10.1086/377694. PMID 15106084.
*Sencer, D. J.; Dull, H. B.; Langmuir, A. D. (Marec 1967). »Epidemiologic basis for eradication of measles in 1967«. Public Health Reports. 82 (3): 253–256. doi:10.2307/4592985. JSTOR 4592985. PMC 1919891. PMID 4960501.
Garnett, G. P. (1. februar 2005). »Role of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted Disease«. The Journal of Infectious Diseases. 191 (Suppl 1): S97–106. doi:10.1086/425271. PMID 15627236.
Quadri-Sheriff, M.; Hendrix, K. S.; Downs, S. M.; Sturm, L. A.; Zimet, G. D.; Finnell, S. M. (september 2012). »The role of herd immunity in parents' decision to vaccinate children: a systematic review«. Pediatrics. 130 (3): 522–530. doi:10.1542/peds.2012-0140. PMID 22926181.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Dubé, E.; Laberge, C.; Guay, M.; Bramadat, P.; Roy, R.; Bettinger, J. (Avgust 2013). »Vaccine hesitancy: an overview«. Human Vaccines & Immunotherapeutics. 9 (8): 1763–1773. doi:10.4161/hv.24657. PMC 3906279. PMID 23584253.
Ropeik, D. (Avgust 2013). »How society should respond to the risk of vaccine rejection«. Human Vaccines & Immunotherapeutics. 9 (8): 1815–1818. doi:10.4161/hv.25250. PMC 3906287. PMID 23807359.
Cesaro, S.; Giacchino, M.; Fioredda, F.; Barone, A.; Battisti, L.; in sod. (2014). »Guidelines on vaccinations in paediatric haematology and oncology patients«. Biomed Res. Int. 2014: 707691. doi:10.1155/2014/707691. PMC 4020520. PMID 24868544.
Munoz, F. M. (2013). »Maternal immunization: An update for pediatricians«. Pediatric Annals. 42 (8): 153–158. doi:10.3928/00904481-20130723-09. PMID 23910028.
Wolfe, R. M. (2012). »Update on adult immunizations«. The Journal of the American Board of Family Medicine. 25 (4): 496–510. doi:10.3122/jabfm.2012.04.100274. PMID 22773718.
Esposito, S; Bosis, S; Morlacchi, L; Baggi, E; Sabatini, C; Principi, N (2012). »Can infants be protected by means of maternal vaccination?«. Clinical Microbiology and Infection. 18 Suppl 5: 85–92. doi:10.1111/j.1469-0691.2012.03936.x. PMID 22862749.
McGirr, A; Fisman, D. N. (2015). »Duration of Pertussis Immunity After DTaP Immunization: A Meta-analysis« (PDF). Pediatrics. 135 (2): 331–43. doi:10.1542/peds.2014-1729. PMID 25560446. Arhivirano iz prvotnega spletišča (PDF) dne 3. marca 2019. Pridobljeno 24. aprila 2020.
Zepp, F; Heininger, U; Mertsola, J; Bernatowska, E; Guiso, N; Roord, J; Tozzi, A. E.; Van Damme, P (2011). »Rationale for pertussis booster vaccination throughout life in Europe«. The Lancet Infectious Diseases. 11 (7): 557–570. doi:10.1016/S1473-3099(11)70007-X. PMID 21600850.
Pittet, L. F.; Posfay-Barbe, K. M. (2012). »Pneumococcal vaccines for children: A global public health priority«. Clinical Microbiology and Infection. 18 Suppl 5: 25–36. doi:10.1111/j.1469-0691.2012.03938.x. PMID 22862432.
Nakagomi, O; Iturriza-Gomara, M; Nakagomi, T; Cunliffe, N. A. (2013). »Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: A review«. Expert Opinion on Biological Therapy. 13 (11): 1613–21. doi:10.1517/14712598.2013.840285. PMID 24088009.
Lopman, B. A.; Payne, D. C.; Tate, J. E.; Patel, M. M.; Cortese, M. M.; Parashar, U. D. (2012). »Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011«. Current Opinion in Virology. 2 (4): 434–42. doi:10.1016/j.coviro.2012.05.002. PMID 22749491.
Kim, T. H. (2014). »Seasonal influenza and vaccine herd effect«. Clinical and Experimental Vaccine Research. 3 (2): 128–32. doi:10.7774/cevr.2014.3.2.128. PMC 4083064. PMID 25003085.
Lowy, D. R.; Schiller, J. T. (2012). »Reducing HPV-associated cancer globally«. Cancer Prevention Research. 5 (1): 18–23. doi:10.1158/1940-6207.CAPR-11-0542. PMC 3285475. PMID 22219162.
Lenzi, A; Mirone, V; Gentile, V; Bartoletti, R; Ficarra, V; Foresta, C; Mariani, L; Mazzoli, S; Parisi, S. G.; Perino, A; Picardo, M; Zotti, C. M. (2013). »Rome Consensus Conference – statement; human papilloma virus diseases in males«. BMC Public Health. 13: 117. doi:10.1186/1471-2458-13-117. PMC 3642007. PMID 23391351.
Garland, S. M.; Skinner, S. R.; Brotherton, J. M. (2011). »Adolescent and young adult HPV vaccination in Australia: Achievements and challenges«. Preventive Medicine. 53 Suppl 1: S29–35. doi:10.1016/j.ypmed.2011.08.015. PMID 21962468.
Perisic, A; Bauch, C. T. (2009). »Social contact networks and disease eradicability under voluntary vaccination«. PLOS Computational Biology. 5 (2): e1000280. Bibcode:2009PLSCB...5E0280P. doi:10.1371/journal.pcbi.1000280. PMC 2625434. PMID 19197342.
Fu, F; Rosenbloom, D. I.; Wang, L; Nowak, M. A. (2011). »Imitation dynamics of vaccination behaviour on social networks« (PDF). Proceedings of the Royal Society B: Biological Sciences. 278 (1702): 42–49. doi:10.1098/rspb.2010.1107. PMC 2992723. PMID 20667876.
Wicker, S; Maltezou, H. C. (2014). »Vaccine-preventable diseases in Europe: Where do we stand?«. Expert Review of Vaccines. 13 (8): 979–87. doi:10.1586/14760584.2014.933077. PMID 24958075.
Rodpothong, P; Auewarakul, P (2012). »Viral evolution and transmission effectiveness«. World Journal of Virology. 1 (5): 131–134. doi:10.5501/wjv.v1.i5.131. PMC 3782273. PMID 24175217.
Corti, D; Lanzavecchia, A (2013). »Broadly neutralizing antiviral antibodies«. Annual Review of Immunology. 31: 705–742. doi:10.1146/annurev-immunol-032712-095916. PMID 23330954.
Bull, R. A.; White, P. A. (2011). »Mechanisms of GII.4 norovirus evolution«. Trends in Microbiology. 19 (5): 233–240. doi:10.1016/j.tim.2011.01.002. PMID 21310617.
Ramani, S; Atmar, R. L.; Estes, M. K. (2014). »Epidemiology of human noroviruses and updates on vaccine development«. Current Opinion in Gastroenterology. 30 (1): 25–33. doi:10.1097/MOG.0000000000000022. PMC 3955997. PMID 24232370.
Pleschka, S (2013). »Overview of Influenza Viruses«. Swine Influenza. Current Topics in Microbiology and Immunology. Zv. 370. str. 1–20. doi:10.1007/82_2012_272. ISBN 978-3642368707. PMID 23124938.
Han, T; Marasco, W. A. (2011). »Structural basis of influenza virus neutralization«. Annals of the New York Academy of Sciences. 1217 (1): 178–190. Bibcode:2011NYASA1217..178H. doi:10.1111/j.1749-6632.2010.05829.x. PMC 3062959. PMID 21251008.
Reperant, L. A.; Rimmelzwaan, G. F.; Osterhaus, A. D. (2014). »Advances in influenza vaccination«. F1000Prime Reports. 6: 47. doi:10.12703/p6-47. PMC 4047948. PMID 24991424.
Weinberger, D. M.; Malley, R; Lipsitch, M (2011). »Serotype replacement in disease after pneumococcal vaccination«. The Lancet. 378 (9807): 1962–1973. doi:10.1016/S0140-6736(10)62225-8. PMC 3256741. PMID 21492929.
McEllistrem, M. C.; Nahm, M. H. (2012). »Novel pneumococcal serotypes 6C and 6D: Anomaly or harbinger«. Clinical Infectious Diseases. 55 (10): 1379–86. doi:10.1093/cid/cis691. PMC 3478140. PMID 22903767.
Dagan, R (2009). »Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae«. Clinical Microbiology and Infection. 15 Suppl 3: 16–20. doi:10.1111/j.1469-0691.2009.02726.x. PMID 19366365.
Lynch Jp, 3rd; Zhanel, G. G. (2010). »Streptococcus pneumoniae: Epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines«. Current Opinion in Pulmonary Medicine. 16 (3): 217–225. doi:10.1097/MCP.0b013e3283385653. PMID 20375783.

harvard.edu

ui.adsabs.harvard.edu

Perisic, A; Bauch, C. T. (2009). »Social contact networks and disease eradicability under voluntary vaccination«. PLOS Computational Biology. 5 (2): e1000280. Bibcode:2009PLSCB...5E0280P. doi:10.1371/journal.pcbi.1000280. PMC 2625434. PMID 19197342.
Han, T; Marasco, W. A. (2011). »Structural basis of influenza virus neutralization«. Annals of the New York Academy of Sciences. 1217 (1): 178–190. Bibcode:2011NYASA1217..178H. doi:10.1111/j.1749-6632.2010.05829.x. PMC 3062959. PMID 21251008.

dash.harvard.edu

Fu, F; Rosenbloom, D. I.; Wang, L; Nowak, M. A. (2011). »Imitation dynamics of vaccination behaviour on social networks« (PDF). Proceedings of the Royal Society B: Biological Sciences. 278 (1702): 42–49. doi:10.1098/rspb.2010.1107. PMC 2992723. PMID 20667876.

jstor.org

*Hinman, A. R.; Orenstein, W. A.; Papania, M. J. (1. maj 2004). »Evolution of measles elimination strategies in the United States«. The Journal of Infectious Diseases. 189 (Suppl 1): S17–22. doi:10.1086/377694. PMID 15106084.
*Sencer, D. J.; Dull, H. B.; Langmuir, A. D. (Marec 1967). »Epidemiologic basis for eradication of measles in 1967«. Public Health Reports. 82 (3): 253–256. doi:10.2307/4592985. JSTOR 4592985. PMC 1919891. PMID 4960501.

nih.gov

pubmed.ncbi.nlm.nih.gov

Fine, P.; Eames, K.; Heymann, D. L. (1. april 2011). »'Herd immunity': A rough guide«. Clinical Infectious Diseases. 52 (7): 911–916. doi:10.1093/cid/cir007. PMID 21427399.
Kim, T. H.; Jonhstone, J.; Loeb, M. (september 2011). »Vaccine herd effect«. Scandinavian Journal of Infectious Diseases. 43 (9): 683–689. doi:10.3109/00365548.2011.582247. PMC 3171704. PMID 21604922.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
*Hinman, A. R.; Orenstein, W. A.; Papania, M. J. (1. maj 2004). »Evolution of measles elimination strategies in the United States«. The Journal of Infectious Diseases. 189 (Suppl 1): S17–22. doi:10.1086/377694. PMID 15106084.
*Sencer, D. J.; Dull, H. B.; Langmuir, A. D. (Marec 1967). »Epidemiologic basis for eradication of measles in 1967«. Public Health Reports. 82 (3): 253–256. doi:10.2307/4592985. JSTOR 4592985. PMC 1919891. PMID 4960501.
Garnett, G. P. (1. februar 2005). »Role of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted Disease«. The Journal of Infectious Diseases. 191 (Suppl 1): S97–106. doi:10.1086/425271. PMID 15627236.
Quadri-Sheriff, M.; Hendrix, K. S.; Downs, S. M.; Sturm, L. A.; Zimet, G. D.; Finnell, S. M. (september 2012). »The role of herd immunity in parents' decision to vaccinate children: a systematic review«. Pediatrics. 130 (3): 522–530. doi:10.1542/peds.2012-0140. PMID 22926181.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Dubé, E.; Laberge, C.; Guay, M.; Bramadat, P.; Roy, R.; Bettinger, J. (Avgust 2013). »Vaccine hesitancy: an overview«. Human Vaccines & Immunotherapeutics. 9 (8): 1763–1773. doi:10.4161/hv.24657. PMC 3906279. PMID 23584253.
Ropeik, D. (Avgust 2013). »How society should respond to the risk of vaccine rejection«. Human Vaccines & Immunotherapeutics. 9 (8): 1815–1818. doi:10.4161/hv.25250. PMC 3906287. PMID 23807359.
Cesaro, S.; Giacchino, M.; Fioredda, F.; Barone, A.; Battisti, L.; in sod. (2014). »Guidelines on vaccinations in paediatric haematology and oncology patients«. Biomed Res. Int. 2014: 707691. doi:10.1155/2014/707691. PMC 4020520. PMID 24868544.
Munoz, F. M. (2013). »Maternal immunization: An update for pediatricians«. Pediatric Annals. 42 (8): 153–158. doi:10.3928/00904481-20130723-09. PMID 23910028.
National Center for Immunization and Respiratory Diseases (2011). »General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP)«. MMWR. Recommendations and Reports / Centers for Disease Control. 60 (2): 1–64. PMID 21293327.
Wolfe, R. M. (2012). »Update on adult immunizations«. The Journal of the American Board of Family Medicine. 25 (4): 496–510. doi:10.3122/jabfm.2012.04.100274. PMID 22773718.
Esposito, S; Bosis, S; Morlacchi, L; Baggi, E; Sabatini, C; Principi, N (2012). »Can infants be protected by means of maternal vaccination?«. Clinical Microbiology and Infection. 18 Suppl 5: 85–92. doi:10.1111/j.1469-0691.2012.03936.x. PMID 22862749.
McGirr, A; Fisman, D. N. (2015). »Duration of Pertussis Immunity After DTaP Immunization: A Meta-analysis« (PDF). Pediatrics. 135 (2): 331–43. doi:10.1542/peds.2014-1729. PMID 25560446. Arhivirano iz prvotnega spletišča (PDF) dne 3. marca 2019. Pridobljeno 24. aprila 2020.
Zepp, F; Heininger, U; Mertsola, J; Bernatowska, E; Guiso, N; Roord, J; Tozzi, A. E.; Van Damme, P (2011). »Rationale for pertussis booster vaccination throughout life in Europe«. The Lancet Infectious Diseases. 11 (7): 557–570. doi:10.1016/S1473-3099(11)70007-X. PMID 21600850.
Pittet, L. F.; Posfay-Barbe, K. M. (2012). »Pneumococcal vaccines for children: A global public health priority«. Clinical Microbiology and Infection. 18 Suppl 5: 25–36. doi:10.1111/j.1469-0691.2012.03938.x. PMID 22862432.
Nakagomi, O; Iturriza-Gomara, M; Nakagomi, T; Cunliffe, N. A. (2013). »Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: A review«. Expert Opinion on Biological Therapy. 13 (11): 1613–21. doi:10.1517/14712598.2013.840285. PMID 24088009.
Lopman, B. A.; Payne, D. C.; Tate, J. E.; Patel, M. M.; Cortese, M. M.; Parashar, U. D. (2012). »Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011«. Current Opinion in Virology. 2 (4): 434–42. doi:10.1016/j.coviro.2012.05.002. PMID 22749491.
Kim, T. H. (2014). »Seasonal influenza and vaccine herd effect«. Clinical and Experimental Vaccine Research. 3 (2): 128–32. doi:10.7774/cevr.2014.3.2.128. PMC 4083064. PMID 25003085.
Lowy, D. R.; Schiller, J. T. (2012). »Reducing HPV-associated cancer globally«. Cancer Prevention Research. 5 (1): 18–23. doi:10.1158/1940-6207.CAPR-11-0542. PMC 3285475. PMID 22219162.
Lenzi, A; Mirone, V; Gentile, V; Bartoletti, R; Ficarra, V; Foresta, C; Mariani, L; Mazzoli, S; Parisi, S. G.; Perino, A; Picardo, M; Zotti, C. M. (2013). »Rome Consensus Conference – statement; human papilloma virus diseases in males«. BMC Public Health. 13: 117. doi:10.1186/1471-2458-13-117. PMC 3642007. PMID 23391351.
Garland, S. M.; Skinner, S. R.; Brotherton, J. M. (2011). »Adolescent and young adult HPV vaccination in Australia: Achievements and challenges«. Preventive Medicine. 53 Suppl 1: S29–35. doi:10.1016/j.ypmed.2011.08.015. PMID 21962468.
Njeumi, F; Taylor, W; Diallo, A; Miyagishima, K; Pastoret, P. P.; Vallat, B; Traore, M (2012). »The long journey: A brief review of the eradication of rinderpest«. Revue Scientifique et Technique (International Office of Epizootics). 31 (3): 729–746. PMID 23520729.
Smith, K. A. (2013). »Smallpox: Can we still learn from the journey to eradication?«. The Indian Journal of Medical Research. 137 (5): 895–899. PMC 3734679. PMID 23760373.
Perisic, A; Bauch, C. T. (2009). »Social contact networks and disease eradicability under voluntary vaccination«. PLOS Computational Biology. 5 (2): e1000280. Bibcode:2009PLSCB...5E0280P. doi:10.1371/journal.pcbi.1000280. PMC 2625434. PMID 19197342.
Fu, F; Rosenbloom, D. I.; Wang, L; Nowak, M. A. (2011). »Imitation dynamics of vaccination behaviour on social networks« (PDF). Proceedings of the Royal Society B: Biological Sciences. 278 (1702): 42–49. doi:10.1098/rspb.2010.1107. PMC 2992723. PMID 20667876.
Wicker, S; Maltezou, H. C. (2014). »Vaccine-preventable diseases in Europe: Where do we stand?«. Expert Review of Vaccines. 13 (8): 979–87. doi:10.1586/14760584.2014.933077. PMID 24958075.
Rodpothong, P; Auewarakul, P (2012). »Viral evolution and transmission effectiveness«. World Journal of Virology. 1 (5): 131–134. doi:10.5501/wjv.v1.i5.131. PMC 3782273. PMID 24175217.
Corti, D; Lanzavecchia, A (2013). »Broadly neutralizing antiviral antibodies«. Annual Review of Immunology. 31: 705–742. doi:10.1146/annurev-immunol-032712-095916. PMID 23330954.
Bull, R. A.; White, P. A. (2011). »Mechanisms of GII.4 norovirus evolution«. Trends in Microbiology. 19 (5): 233–240. doi:10.1016/j.tim.2011.01.002. PMID 21310617.
Ramani, S; Atmar, R. L.; Estes, M. K. (2014). »Epidemiology of human noroviruses and updates on vaccine development«. Current Opinion in Gastroenterology. 30 (1): 25–33. doi:10.1097/MOG.0000000000000022. PMC 3955997. PMID 24232370.
Pleschka, S (2013). »Overview of Influenza Viruses«. Swine Influenza. Current Topics in Microbiology and Immunology. Zv. 370. str. 1–20. doi:10.1007/82_2012_272. ISBN 978-3642368707. PMID 23124938.
Han, T; Marasco, W. A. (2011). »Structural basis of influenza virus neutralization«. Annals of the New York Academy of Sciences. 1217 (1): 178–190. Bibcode:2011NYASA1217..178H. doi:10.1111/j.1749-6632.2010.05829.x. PMC 3062959. PMID 21251008.
Reperant, L. A.; Rimmelzwaan, G. F.; Osterhaus, A. D. (2014). »Advances in influenza vaccination«. F1000Prime Reports. 6: 47. doi:10.12703/p6-47. PMC 4047948. PMID 24991424.
Weinberger, D. M.; Malley, R; Lipsitch, M (2011). »Serotype replacement in disease after pneumococcal vaccination«. The Lancet. 378 (9807): 1962–1973. doi:10.1016/S0140-6736(10)62225-8. PMC 3256741. PMID 21492929.
McEllistrem, M. C.; Nahm, M. H. (2012). »Novel pneumococcal serotypes 6C and 6D: Anomaly or harbinger«. Clinical Infectious Diseases. 55 (10): 1379–86. doi:10.1093/cid/cis691. PMC 3478140. PMID 22903767.
Dagan, R (2009). »Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae«. Clinical Microbiology and Infection. 15 Suppl 3: 16–20. doi:10.1111/j.1469-0691.2009.02726.x. PMID 19366365.
Lynch Jp, 3rd; Zhanel, G. G. (2010). »Streptococcus pneumoniae: Epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines«. Current Opinion in Pulmonary Medicine. 16 (3): 217–225. doi:10.1097/MCP.0b013e3283385653. PMID 20375783.

ncbi.nlm.nih.gov

Kim, T. H.; Jonhstone, J.; Loeb, M. (september 2011). »Vaccine herd effect«. Scandinavian Journal of Infectious Diseases. 43 (9): 683–689. doi:10.3109/00365548.2011.582247. PMC 3171704. PMID 21604922.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
*Hinman, A. R.; Orenstein, W. A.; Papania, M. J. (1. maj 2004). »Evolution of measles elimination strategies in the United States«. The Journal of Infectious Diseases. 189 (Suppl 1): S17–22. doi:10.1086/377694. PMID 15106084.
*Sencer, D. J.; Dull, H. B.; Langmuir, A. D. (Marec 1967). »Epidemiologic basis for eradication of measles in 1967«. Public Health Reports. 82 (3): 253–256. doi:10.2307/4592985. JSTOR 4592985. PMC 1919891. PMID 4960501.
Dubé, E.; Laberge, C.; Guay, M.; Bramadat, P.; Roy, R.; Bettinger, J. (Avgust 2013). »Vaccine hesitancy: an overview«. Human Vaccines & Immunotherapeutics. 9 (8): 1763–1773. doi:10.4161/hv.24657. PMC 3906279. PMID 23584253.
Ropeik, D. (Avgust 2013). »How society should respond to the risk of vaccine rejection«. Human Vaccines & Immunotherapeutics. 9 (8): 1815–1818. doi:10.4161/hv.25250. PMC 3906287. PMID 23807359.
Cesaro, S.; Giacchino, M.; Fioredda, F.; Barone, A.; Battisti, L.; in sod. (2014). »Guidelines on vaccinations in paediatric haematology and oncology patients«. Biomed Res. Int. 2014: 707691. doi:10.1155/2014/707691. PMC 4020520. PMID 24868544.
Kim, T. H. (2014). »Seasonal influenza and vaccine herd effect«. Clinical and Experimental Vaccine Research. 3 (2): 128–32. doi:10.7774/cevr.2014.3.2.128. PMC 4083064. PMID 25003085.
Lowy, D. R.; Schiller, J. T. (2012). »Reducing HPV-associated cancer globally«. Cancer Prevention Research. 5 (1): 18–23. doi:10.1158/1940-6207.CAPR-11-0542. PMC 3285475. PMID 22219162.
Lenzi, A; Mirone, V; Gentile, V; Bartoletti, R; Ficarra, V; Foresta, C; Mariani, L; Mazzoli, S; Parisi, S. G.; Perino, A; Picardo, M; Zotti, C. M. (2013). »Rome Consensus Conference – statement; human papilloma virus diseases in males«. BMC Public Health. 13: 117. doi:10.1186/1471-2458-13-117. PMC 3642007. PMID 23391351.
Smith, K. A. (2013). »Smallpox: Can we still learn from the journey to eradication?«. The Indian Journal of Medical Research. 137 (5): 895–899. PMC 3734679. PMID 23760373.
Perisic, A; Bauch, C. T. (2009). »Social contact networks and disease eradicability under voluntary vaccination«. PLOS Computational Biology. 5 (2): e1000280. Bibcode:2009PLSCB...5E0280P. doi:10.1371/journal.pcbi.1000280. PMC 2625434. PMID 19197342.
Fu, F; Rosenbloom, D. I.; Wang, L; Nowak, M. A. (2011). »Imitation dynamics of vaccination behaviour on social networks« (PDF). Proceedings of the Royal Society B: Biological Sciences. 278 (1702): 42–49. doi:10.1098/rspb.2010.1107. PMC 2992723. PMID 20667876.
Rodpothong, P; Auewarakul, P (2012). »Viral evolution and transmission effectiveness«. World Journal of Virology. 1 (5): 131–134. doi:10.5501/wjv.v1.i5.131. PMC 3782273. PMID 24175217.
Ramani, S; Atmar, R. L.; Estes, M. K. (2014). »Epidemiology of human noroviruses and updates on vaccine development«. Current Opinion in Gastroenterology. 30 (1): 25–33. doi:10.1097/MOG.0000000000000022. PMC 3955997. PMID 24232370.
Han, T; Marasco, W. A. (2011). »Structural basis of influenza virus neutralization«. Annals of the New York Academy of Sciences. 1217 (1): 178–190. Bibcode:2011NYASA1217..178H. doi:10.1111/j.1749-6632.2010.05829.x. PMC 3062959. PMID 21251008.
Reperant, L. A.; Rimmelzwaan, G. F.; Osterhaus, A. D. (2014). »Advances in influenza vaccination«. F1000Prime Reports. 6: 47. doi:10.12703/p6-47. PMC 4047948. PMID 24991424.
Weinberger, D. M.; Malley, R; Lipsitch, M (2011). »Serotype replacement in disease after pneumococcal vaccination«. The Lancet. 378 (9807): 1962–1973. doi:10.1016/S0140-6736(10)62225-8. PMC 3256741. PMID 21492929.
McEllistrem, M. C.; Nahm, M. H. (2012). »Novel pneumococcal serotypes 6C and 6D: Anomaly or harbinger«. Clinical Infectious Diseases. 55 (10): 1379–86. doi:10.1093/cid/cis691. PMC 3478140. PMID 22903767.

ox.ac.uk

vk.ovg.ox.ac.uk

»Herd Immunity«. Oxford Vaccine Group, University of Oxford. Pridobljeno 12. decembra 2017.

oxfordjournals.org

jid.oxfordjournals.org

*Hinman, A. R.; Orenstein, W. A.; Papania, M. J. (1. maj 2004). »Evolution of measles elimination strategies in the United States«. The Journal of Infectious Diseases. 189 (Suppl 1): S17–22. doi:10.1086/377694. PMID 15106084.
*Sencer, D. J.; Dull, H. B.; Langmuir, A. D. (Marec 1967). »Epidemiologic basis for eradication of measles in 1967«. Public Health Reports. 82 (3): 253–256. doi:10.2307/4592985. JSTOR 4592985. PMC 1919891. PMID 4960501.
Garnett, G. P. (1. februar 2005). »Role of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted Disease«. The Journal of Infectious Diseases. 191 (Suppl 1): S97–106. doi:10.1086/425271. PMID 15627236.

cid.oxfordjournals.org

Fine, P.; Eames, K.; Heymann, D. L. (1. april 2011). »'Herd immunity': A rough guide«. Clinical Infectious Diseases. 52 (7): 911–916. doi:10.1093/cid/cir007. PMID 21427399.

semanticscholar.org

pdfs.semanticscholar.org

McGirr, A; Fisman, D. N. (2015). »Duration of Pertussis Immunity After DTaP Immunization: A Meta-analysis« (PDF). Pediatrics. 135 (2): 331–43. doi:10.1542/peds.2014-1729. PMID 25560446. Arhivirano iz prvotnega spletišča (PDF) dne 3. marca 2019. Pridobljeno 24. aprila 2020.

termania.net

https://www.termania.net/slovarji/mikrobioloski-slovar/5545583/antigenski-premik?query=shift&SearchIn=All&sl=61, Mikrobiološki slovar - Slovensko mikrobiološko društvo, vpogled: 26. 4. 2020.

web.archive.org

McGirr, A; Fisman, D. N. (2015). »Duration of Pertussis Immunity After DTaP Immunization: A Meta-analysis« (PDF). Pediatrics. 135 (2): 331–43. doi:10.1542/peds.2014-1729. PMID 25560446. Arhivirano iz prvotnega spletišča (PDF) dne 3. marca 2019. Pridobljeno 24. aprila 2020.

zenodo.org

Lopman, B. A.; Payne, D. C.; Tate, J. E.; Patel, M. M.; Cortese, M. M.; Parashar, U. D. (2012). »Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011«. Current Opinion in Virology. 2 (4): 434–42. doi:10.1016/j.coviro.2012.05.002. PMID 22749491.